| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |